Revance Therapeutics Stock Price

0.00 (0.0%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 26.06 04:00:00
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
25.50 32.00 6.50 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 26.06 USD

Revance Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.73B 66.55M 59.10M $ 413.00k $ - -3.67 -6.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Revance Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVNC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week26.0027.0924.9426.06475,2690.060.23%
1 Month28.0430.3524.9427.58431,027-1.98-7.06%
3 Months24.9330.4523.7727.55470,1441.134.53%
6 Months28.4834.6222.8927.41561,060-2.42-8.5%
1 Year23.2634.6211.7823.63578,5162.8012.04%
3 Years32.9534.629.8821.42475,733-6.89-20.91%
5 Years18.8037.459.8821.97385,5067.2638.62%

Revance Therapeutics Description

Revance Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company's proprietary peptide technology enables the delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. The company is pursuing clinical development for RT002 injectable in a broad spectrum of aesthetic and therapeutic indications.

Your Recent History
Revance Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.